Literature DB >> 17804642

p53 RNA interactions: new clues in an old mystery.

Kasandra J-L Riley1, L James Maher.   

Abstract

The p53 tumor suppressor protein is typically considered to be a sequence-specific DNA-binding transcription factor. However, reports over the last 15 years have described RNA binding by p53 in a variety of contexts, suggesting the possibility of new p53 functions. It is clear that p53-RNA interactions are mediated by a nucleic acid-binding domain of p53 independent of the sequence-specific core domain responsible for DNA recognition. Reports disagree on several aspects of the putative RNA interaction, including sequence specificity and biological relevance. Here we review the history and recent advances in the study of p53-RNA interactions. We argue that p53-RNA interactions are sequence nonspecific and depend on incomplete post-translational modification of the p53 C-terminal domain when the protein is expressed in heterologous systems. It is unknown what fraction of p53 protein exists in a state competent for RNA binding in vivo. Thus, potential physiological roles of p53-RNA interactions remain mysterious.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17804642      PMCID: PMC2040099          DOI: 10.1261/rna.673407

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  81 in total

1.  p53: more research and more questions.

Authors:  A W Braithwaite; C L Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

2.  p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.

Authors:  L Liu; D M Scolnick; R C Trievel; H B Zhang; R Marmorstein; T D Halazonetis; S L Berger
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

3.  Thymidylate synthase protein and p53 mRNA form an in vivo ribonucleoprotein complex.

Authors:  E Chu; S M Copur; J Ju; T M Chen; S Khleif; D M Voeller; N Mizunuma; M Patel; G F Maley; F Maley; C J Allegra
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

4.  ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins.

Authors:  M J Waterman; E S Stavridi; J L Waterman; T D Halazonetis
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

5.  DNA damage activates p53 through a phosphorylation-acetylation cascade.

Authors:  K Sakaguchi; J E Herrera; S Saito; T Miki; M Bustin; A Vassilev; C W Anderson; E Appella
Journal:  Genes Dev       Date:  1998-09-15       Impact factor: 11.361

6.  Metal and RNA binding properties of the hdm2 RING finger domain.

Authors:  Z Lai; D A Freedman; A J Levine; G L McLendon
Journal:  Biochemistry       Date:  1998-12-01       Impact factor: 3.162

7.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

8.  Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.

Authors:  W Gu; R G Roeder
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

9.  Effect of phosphorylation on tetramerization of the tumor suppressor protein p53.

Authors:  K Sakaguchi; H Sakamoto; D Xie; J W Erickson; M S Lewis; C W Anderson; E Appella
Journal:  J Protein Chem       Date:  1997-07

10.  Reversible inactivation of the transcriptional function of P53 protein by farnesylation.

Authors:  Bettina Couderc; Marie Penary; Mustapha Tohfe; Anne Pradines; Antoine Casteignau; Danièle Berg; Gilles Favre
Journal:  BMC Biotechnol       Date:  2006-05-29       Impact factor: 2.563

View more
  30 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  Emerging paradigms of regulated microRNA processing.

Authors:  Martin A Newman; Scott M Hammond
Journal:  Genes Dev       Date:  2010-06-01       Impact factor: 11.361

Review 3.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

4.  Analysis of p53-RNA interactions in cultured human cells.

Authors:  Kasandra J-L Riley; L James Maher
Journal:  Biochem Biophys Res Commun       Date:  2007-09-10       Impact factor: 3.575

5.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

6.  Prosurvival long noncoding RNA PINCR regulates a subset of p53 targets in human colorectal cancer cells by binding to Matrin 3.

Authors:  Ritu Chaudhary; Berkley Gryder; Wendy S Woods; Murugan Subramanian; Matthew F Jones; Xiao Ling Li; Lisa M Jenkins; Svetlana A Shabalina; Min Mo; Mary Dasso; Yuan Yang; Lalage M Wakefield; Yuelin Zhu; Susan M Frier; Branden S Moriarity; Kannanganattu V Prasanth; Pablo Perez-Pinera; Ashish Lal
Journal:  Elife       Date:  2017-06-05       Impact factor: 8.140

7.  Distinct modulatory role of RNA in the aggregation of the tumor suppressor protein p53 core domain.

Authors:  Petar Stefanov Kovachev; Debapriya Banerjee; Luciana Pereira Rangel; Jonny Eriksson; Murilo M Pedrote; Mafalda Maria D C Martins-Dinis; Katarina Edwards; Yraima Cordeiro; Jerson L Silva; Suparna Sanyal
Journal:  J Biol Chem       Date:  2017-04-18       Impact factor: 5.157

8.  The DEAD-box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1 mRNA translation.

Authors:  Dominik Peters; Claudia Radine; Alina Reese; Wilfried Budach; Dennis Sohn; Reiner U Jänicke
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

Review 9.  The nucleolus under stress.

Authors:  Séverine Boulon; Belinda J Westman; Saskia Hutten; François-Michel Boisvert; Angus I Lamond
Journal:  Mol Cell       Date:  2010-10-22       Impact factor: 17.970

10.  Cooperativity dominates the genomic organization of p53-response elements: a mechanistic view.

Authors:  Yongping Pan; Ruth Nussinov
Journal:  PLoS Comput Biol       Date:  2009-07-24       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.